Alex Azar faces skepticism regarding his ability to regulate drug prices given his past employment; Kellyanne Conway is named America's opioid czar; a study finds childhood trauma can have a generational impact.
During hearings on his nomination for HHS secretary, Alex Azar faced tough questions about how he would handle high drug costs. According to The New York Times, Azar faced distrust about claims to regulate the drug industry because of his past experience as an executive at Eli Lilly. While most Republicans viewed his experience in the drug industry as a benefit to help him understand and improve drug prices, Democrats and Senator Rand Paul, R-Kentucky, expressed skepticism due to Eli Lilly’s own past of steep drug price hikes.
In response to the continued opioid epidemic in the United States, President Donald Trump has appointed Kellyanne Conway, who is currently serving as counselor to Trump, as the country’s “opioid czar.” Whether or not Conway will focus solely on this new position, or continue to work as a counselor is unclear, reported Newsweek. Conway’s job as czar will be to “change the perception” around opioids. When Attorney General Jeff Sessions announced the appointment, he also said that all US attorney offices will designate an opioid coordinator to “determine which cases should be prosecuted at the federal level.”
Childhood trauma can have long-lasting effects and even increase the risk of serious psychiatric disorders for the daughters of women exposed to trauma. A new study tracked the health of female and male children born to children evacuated during World War II and found the female children of mothers were more likely to be hospitalized for psychiatric illness. No effects were found among male children born to the women or among children of either gender both to fathers who had been evacuated as children. The researchers postulate that traumatic events can change gene expression, which is inherited from mother to daughter.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More